XILIO THERAPEUTICS INC COM is a security (CUSIP 98422T209) tracked across SEC portfolio filings. 19 institutional managers reported $14.7M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $605K via N-PORT as of 2026-05-29.
Showing 15 of 19 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | Boston, MA | $5.6M | 664,021 |
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $3.6M | 422,505 |
| Sio Capital Management, LLC | New York, NY | $1.3M | 152,464 |
| Caligan Partners LP | New York, NY | $943K | 112,128 |
| Merck & Co., Inc. | RAHWAY, NJ | $891K | 105,982 |
| Stonepine Capital Management, LLC | Bend, OR | $540K | 64,162 |
| MORGAN STANLEY | NEW YORK, NY | $484K | 57,493 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $417K | 49,566 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $313K | 37,197 |
| FMR LLC | BOSTON, MA | $307K | 36,558 |
| Velan Capital Investment Management LP | Alpharetta, GA | $120K | 14,285 |
| Ghisallo Capital Management LLC | Greenwich, CT | $116K | 13,800 |
| STATE STREET CORP | BOSTON, MA | $112K | 13,311 |
| CWM, LLC | OMAHA, NE | $35K | 4,206 |
| UBS Group AG | Zurich, V8 | $34K | 4,038 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $495K | 0.06% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $110K | 0.04% |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $25 | 0.00% |